Ibaraki, Japan

Haraku Itadani


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Haraku Itadani: Innovator in G Protein-Coupled Receptor Research

Introduction

Haraku Itadani is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of biochemistry, particularly in the study of G protein-coupled receptors (GPCRs). His innovative work has led to advancements in pharmaceutical research and development.

Latest Patents

Haraku Itadani holds a patent for a method of screening for a compound using guanosine triphosphate (GTP)-binding protein-coupled receptor protein, specifically the novel GPCR known as BG37. This patent describes a process where a similarity search of the amino acid sequence of known G protein-coupled receptor proteins in GenBank was conducted. The result was the identification of a novel human GPCR gene, BG37. The cDNA containing the open reading frame (ORF) of this gene was cloned, and its nucleotide sequence was determined. Additionally, novel GPCR BG37 genes from mouse and rat were isolated. The use of this novel GPCR enables the screening of ligands, compounds that inhibit binding to a ligand, and candidate pharmaceutical compounds that can regulate signal transduction from the BG37 receptor.

Career Highlights

Haraku Itadani has had a distinguished career in the pharmaceutical industry. He is currently associated with Banyu Pharmaceutical Co. Ltd., where he continues to contribute to innovative research in drug development. His work has been instrumental in advancing the understanding of GPCRs and their potential therapeutic applications.

Collaborations

Throughout his career, Haraku Itadani has collaborated with esteemed colleagues, including Takaharu Maruyama and Takao Nakamura. These collaborations have fostered a productive research environment, leading to significant advancements in their field.

Conclusion

Haraku Itadani's contributions to the field of biochemistry, particularly in GPCR research, have paved the way for new pharmaceutical developments. His innovative patent and collaborative efforts highlight his commitment to advancing scientific knowledge and improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…